175 related articles for article (PubMed ID: 3058234)
1. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
Nieuwenhuizen W
Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
Kroneman H; Nieuwenhuizen W; Knot EA
Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
[TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
Greenberg CS; Devine DV; McCrae KM
Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
5. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
[TBL] [Abstract][Full Text] [Related]
6. Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodies.
Kroneman H; Nieuwenhuizen W; Knot EA; Van Bergen PF; De Maat MP
Thromb Res; 1991 Feb; 61(4):441-52. PubMed ID: 1953861
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
8. An immunoassay for human D dimer using monoclonal antibodies.
Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
[TBL] [Abstract][Full Text] [Related]
9. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
[TBL] [Abstract][Full Text] [Related]
10. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Am J Clin Pathol; 1986 Mar; 85(3):360-4. PubMed ID: 2875646
[TBL] [Abstract][Full Text] [Related]
12. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the assay for fibrin derivatives using monoclonal antibodies to D-dimer].
Arai M; Kuroso K; Ikematsu S; Fujimaki M; Fukutake K
Rinsho Byori; 1986 Feb; 34(2):157-61. PubMed ID: 3517428
[No Abstract] [Full Text] [Related]
14. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
15. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
Godal HC; Hamborg T
Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products.
Connaghan DG; Francis CW; Ryan DH; Marder VJ
Am J Clin Pathol; 1986 Sep; 86(3):304-10. PubMed ID: 3751995
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
[TBL] [Abstract][Full Text] [Related]
20. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
Kawai Y
Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
